Jonathan Berlent has been appointed vice president of business development at Tris Pharma. He will lead the company’s product and technology partnering, and collaborate with branded pharmaceutical companies on their life cycle management opportunities.   “As Tris scales up its effort to address the growing unmet need in the industry for liquid extended release technology, Jonathan will lead business development efforts and be our point person with branded pharmaceutical companies,” said Ketan Me...